Affymetrix Expands the Expression Power of the GeneAtlas(R) Personal Microarray System

Affymetrix, Inc. (NASDAQ:AFFX) today announced the availability of the most widely cited gene expression microarray for use on the GeneAtlas(R) Personal Microarray System, bringing the power of the world’s largest collection of referenced microarray gene expression data to the personal bench-top of every life scientist. The new array strip format for the GeneChip(R) Human Genome(HG)-U133 Array combined with the easy workflow of the GeneAtlas System gives researchers a cost-effective solution for in-house whole-genome expression analysis.

Source: Affymetrix